Abrinica, Clyde .

HRN: 27-22-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/16/2025
CEFUROXIME 750MG (VIAL)
09/16/2025
09/22/2025
IVT
250mg
Q8
Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines